World Diabetes Day awareness

Message from WHO Regional Director for Africa, Dr Matshidiso Moeti On 14 November, the international community commemorates World Diabetes Day to raise awareness of the growing burden of this disease, and strategies to prevent and treat it. The theme this year, and until 2023, is “Access to diabetes care” because too many people still do…

New software to capture worldwide cancer data launched

CanStaging⁺, a user-friendly tool aimed at facilitating the recording of comparable cancer staging data worldwide, has been launched. The tool has been developed by researchers from Queen’s University Belfast, the Northern Ireland Cancer Registry (NICR), the International Agency for Research on Cancer and the Union for International Cancer Control (UICC). CanStaging+ will facilitate the recording…

Progress on Broadly Neutralizing Antibodies, Injectable PrEP, and Other New HIV Prevention Strategies Announced at HIV Research for Prevention Conference

26 January 2021 – Important advances in HIV prevention research were announced today at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), convened by IAS – the International AIDS Society. Highlights included findings from a pair of trials evaluating whether infusions with a broadly neutralizing antibody (bNAb) can prevent HIV acquisition and positive…

A Landmark trial in East and Southern Africa finds injectable PrEP safe and effective for cisgender women

Regulatory review and introduction plans must be accelerated New York City, November 9, 2020— AVAC enthusiastically welcomes the news that another trial of the long-acting, injectable antiretroviral cabotegravir (CAB-LA) for HIV prevention for HIV pre-exposure prophylaxis (PrEP) has demonstrated safety and efficacy, this time among cisgender women. Today’s announcement from ViiV, the US National Institute of Allergy and…